Strobeck Mark

Track

Insider profile

Strobeck Mark's trades of Zyla Life Sciences's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
113.69
Quantity 78,082 +22.4%
Value US$3,368,332
Transaction date
Planned sale
Price
374.92
Quantity 16,149 +5.0%
Value US$1,681,772
Transaction date
Planned sale
Price
331.32
Quantity 61,170 +39.5%
Value US$2,336,111
Transaction date
Planned sale
Price
7.55
Quantity 8,700 -10.8%
Value US$65,685
Transaction date
Planned sale
Price
4.68
Quantity 8,700 -9.7%
Value US$40,716
Transaction date
Planned sale
Price
10.40
Quantity 8,700 -8.2%
Value US$90,480
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2017-10-03 2017-10-02
PlS Planned sale
78,082 +22.4%
113.69
US$3,368,332 		78,082 +22.4% 113.69 US$3,368,332
2017-07-05 2017-06-30
PlS Planned sale
16,149 +5.0%
374.92
US$1,681,772 		16,149 +5.0% 374.92 US$1,681,772
2017-01-04 2016-12-30
PlS Planned sale
61,170 +39.5%
331.32
US$2,336,111 		61,170 +39.5% 331.32 US$2,336,111
2016-10-03 2016-09-30
PlS Planned sale
8,700 -10.8%
7.55
US$65,685 		8,700 -10.8% 7.55 US$65,685
2016-07-05 2016-06-30
PlS Planned sale
8,700 -9.7%
4.68
US$40,716 		8,700 -9.7% 4.68 US$40,716
2016-01-05 2015-12-31
PlS Planned sale
8,700 -8.2%
10.40
US$90,480 		8,700 -8.2% 10.40 US$90,480